FIRMAGON® Intensive Drug Monitoring

Clinical trial NCT05181800 · COMPLETED

Trial details

NCT number: NCT05181800
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2019-08-20
Primary completion: 2022-12-31
Enrollment: 1454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.